BACKGROUND Risk-stratified management of fever with neutropenia (FN), allows intensive management of high-risk cases and early discharge of low-risk cases. No single, internationally validated, prediction model of the risk of adverse outcomes exists for children and young people. An individual patient data (IPD) meta-analysis was undertaken to devise one. METHODS The 'Predicting Infectious Complications in Children with Cancer' (PICNICC) collaboration was formed by parent representatives, international clinical and methodological experts. Univariable and multivariable analyses, using random effects logistic regression, were undertaken to derive and internally validate a risk-prediction model for outcomes of episodes of FN based on ...
BACKGROUND: Fever in severe chemotherapy-induced neutropenia (FN) is the most frequent manifestation...
STUDY AIM:: To develop a score predicting the risk of bacteremia in cancer patients with fever and n...
BACKGROUND: Risk-stratified approaches to managing cancer therapies and their consequent complicatio...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Abstract Background A common and potentially life-threatening complication of the treatment of child...
BACKGROUND: Risk-stratified approaches to managing cancer therapies and their consequent complicatio...
BACKGROUND: Fever in severe chemotherapy-induced neutropenia (FN) is the most frequent manifestation...
STUDY AIM:: To develop a score predicting the risk of bacteremia in cancer patients with fever and n...
BACKGROUND: Risk-stratified approaches to managing cancer therapies and their consequent complicatio...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
BACKGROUND: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Background: Risk-stratified management of fever with neutropenia (FN), allows intensive management o...
Abstract Background A common and potentially life-threatening complication of the treatment of child...
BACKGROUND: Risk-stratified approaches to managing cancer therapies and their consequent complicatio...
BACKGROUND: Fever in severe chemotherapy-induced neutropenia (FN) is the most frequent manifestation...
STUDY AIM:: To develop a score predicting the risk of bacteremia in cancer patients with fever and n...
BACKGROUND: Risk-stratified approaches to managing cancer therapies and their consequent complicatio...